Overview

A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus

Status:
Completed
Trial end date:
2019-01-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effect of ticagrelor versus placebo in patients with Type 2 Diabetes Mellitus.
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Treatments:
Adenosine
Ticagrelor